These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

952 related items for PubMed ID: 16679275

  • 1. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N, Morales H, Modrego PJ, Pina MA.
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [Abstract] [Full Text] [Related]

  • 2. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N, Dávila J, Medrano J, Olmos S.
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [Abstract] [Full Text] [Related]

  • 3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
    Zeng Q, Liu H, Zhang K, Li C, Zhou G.
    Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
    [Abstract] [Full Text] [Related]

  • 6. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ.
    NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
    Toyooka M, Kimura H, Uematsu H, Kawamura Y, Takeuchi H, Itoh H.
    Clin Imaging; 2008 Feb; 32(4):251-8. PubMed ID: 18603178
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
    Zhou GF, Wang XY, Gong CG, Liu F, Wang RW.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW.
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.